Home  ›  Tamoxifen and Weight Loss Diet

Tamoxifen and Weight Loss Diet

Written By Wednesday, December 1, 2021 Add Comment Edit

Clinical Trial

doi: 10.1007/BF00665695.

The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients

Affiliations

  • PMID: 8312583
  • DOI: 10.1007/BF00665695

Clinical Trial

The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients

D P Rose  et al. Breast Cancer Res Treat. 1993 Sep .

Abstract

The purpose of the study was to determine the effect of a low-fat dietary intervention, with or without concomitant tamoxifen adjuvant therapy, on serum estrogen and sex hormone-binding globulin (SHBG) levels in postmenopausal patients with resected breast cancer. Ninety-three patients were randomized to either reduce their fat intake to 15-20% of total calories, or to a dietary control group. Serum estradiol, estrone, estrone sulfate, and SHBG concentrations were assayed at baseline, and at 6, 12, and 18 months thereafter. In 19% of patients, the preintervention serum estradiol levels were below the sensitivity of the assay (5 pg/ml). Tamoxifen had no significant effect on serum estrogen levels, but produced an elevation in SHBG. Patients with reliably quantifiable preintervention estradiol concentrations (> or = 10 pg/ml) showed a significant reduction in serum estradiol after 6 months on the low-fat diet (average, 20%; p < 0.005); this was sustained over the 18 month study period. Serum SHBG levels were increased by tamoxifen therapy, but were reduced significantly (p = 0.01) after 12 months on the low-fat diet in patients not receiving tamoxifen. No changes in serum estrone or estrone sulfate resulted from the dietary intervention. While the low-fat diet produced significant weight loss, patients treated with tamoxifen without dietary intervention showed a gain in body weight. These weight changes produced disruptions in the normal positive correlation between body weight and serum estrone sulfate, and the negative correlation with SHBG concentration.

Similar articles

  • Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients.

    Rose DP, Chlebowski RT, Connolly JM, Jones LA, Wynder EL. Rose DP, et al. Cancer Res. 1992 Oct 1;52(19):5386-90. Cancer Res. 1992. PMID: 1394142 Clinical Trial.

  • Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.

    Pasquali R, Vicennati V, Bertazzo D, Casimirri F, Pascal G, Tortelli O, Labate AM. Pasquali R, et al. Metabolism. 1997 Jan;46(1):5-9. doi: 10.1016/s0026-0495(97)90159-1. Metabolism. 1997. PMID: 9005961

  • Effects of a very low fat, high fiber diet on serum hormones and menstrual function. Implications for breast cancer prevention.

    Bagga D, Ashley JM, Geffrey SP, Wang HJ, Barnard RJ, Korenman S, Heber D. Bagga D, et al. Cancer. 1995 Dec 15;76(12):2491-6. doi: 10.1002/1097-0142(19951215)76:12<2491::aid-cncr2820761213>3.0.co;2-r. Cancer. 1995. PMID: 8625075

  • The role of free fatty acids in regulating the tissue availability and synthesis of sex steroids.

    Reed MJ, Dunkley SA, Singh A, Thomas BS, Haines AP, Cruickshank JK. Reed MJ, et al. Prostaglandins Leukot Essent Fatty Acids. 1993 Jan;48(1):111-6. doi: 10.1016/0952-3278(93)90018-r. Prostaglandins Leukot Essent Fatty Acids. 1993. PMID: 8424117 Review.

  • Adjuvant dietary fat intake reduction in postmenopausal breast cancer patient management. The Women's Intervention Nutrition Study (WINS).

    Chlebowski RT, Rose D, Buzzard IM, Blackburn GL, Insull W Jr, Grosvenor M, Elashoff R, Wynder EL. Chlebowski RT, et al. Breast Cancer Res Treat. 1992 Jan;20(2):73-84. doi: 10.1007/BF01834637. Breast Cancer Res Treat. 1992. PMID: 1554890 Review.

Cited by 22 articles

  • Reduction in saturated fat intake for cardiovascular disease.

    Hooper L, Martin N, Jimoh OF, Kirk C, Foster E, Abdelhamid AS. Hooper L, et al. Cochrane Database Syst Rev. 2020 Aug 21;8(8):CD011737. doi: 10.1002/14651858.CD011737.pub3. Cochrane Database Syst Rev. 2020. PMID: 32827219 Free PMC article.

  • Effects of total fat intake on body fatness in adults.

    Hooper L, Abdelhamid AS, Jimoh OF, Bunn D, Skeaff CM. Hooper L, et al. Cochrane Database Syst Rev. 2020 Jun 1;6(6):CD013636. doi: 10.1002/14651858.CD013636. Cochrane Database Syst Rev. 2020. PMID: 32476140 Free PMC article.

  • Reduction in saturated fat intake for cardiovascular disease.

    Hooper L, Martin N, Jimoh OF, Kirk C, Foster E, Abdelhamid AS. Hooper L, et al. Cochrane Database Syst Rev. 2020 May 19;5(5):CD011737. doi: 10.1002/14651858.CD011737.pub2. Cochrane Database Syst Rev. 2020. PMID: 32428300 Free PMC article. Updated.

  • Omega-6 fats for the primary and secondary prevention of cardiovascular disease.

    Hooper L, Al-Khudairy L, Abdelhamid AS, Rees K, Brainard JS, Brown TJ, Ajabnoor SM, O'Brien AT, Winstanley LE, Donaldson DH, Song F, Deane KH. Hooper L, et al. Cochrane Database Syst Rev. 2018 Nov 29;11(11):CD011094. doi: 10.1002/14651858.CD011094.pub4. Cochrane Database Syst Rev. 2018. PMID: 30488422 Free PMC article.

  • Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease.

    Abdelhamid AS, Martin N, Bridges C, Brainard JS, Wang X, Brown TJ, Hanson S, Jimoh OF, Ajabnoor SM, Deane KH, Song F, Hooper L. Abdelhamid AS, et al. Cochrane Database Syst Rev. 2018 Nov 27;11(11):CD012345. doi: 10.1002/14651858.CD012345.pub3. Cochrane Database Syst Rev. 2018. PMID: 30484282 Free PMC article.

References

    1. JAMA. 1992 Oct 21;268(15):2037-44 - PubMed
    1. J Clin Oncol. 1990 Aug;8(8):1327-34 - PubMed
    1. Cancer Res. 1987 Jan 15;47(2):624-30 - PubMed
    1. Cancer Res. 1992 Oct 1;52(19):5386-90 - PubMed
    1. Steroidologia. 1970;1(3):129-36 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

  • Other Literature Sources

    • The Lens - Patent Citations

  • Medical

    • Genetic Alliance
    • MedlinePlus Health Information

  • Miscellaneous

    • NCI CPTAC Assay Portal

Tamoxifen and Weight Loss Diet

Source: https://pubmed.ncbi.nlm.nih.gov/8312583/

0 Response to "Tamoxifen and Weight Loss Diet"

Post a Comment

Subscribe to: Post Comments (Atom)

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel